Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118539) titled 'Efficacy and Mechanism Exploration of Imaxitinib in Psoriasis' on Feb. 6.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Binzhou Medical University Hospital
Condition:
Psoriasis
Intervention:
Ivarmacitinib Sulfate Group:None
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-02-28
Target Sample Size: Ivarmacitinib Sulfate Group:20;Basic treatment group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=299105
Disclaimer: Curated by HT Syndication....